J Studios/DigitalVision via Getty Images
HUTCHMED (China) Limited (NASDAQ: HCM) on Wednesday announced arrangements to divest 45% of its equity ownership in Shanghai Hutchison Pharmaceuticals Limited, its joint venture with Shanghai Pharmaceuticals Holding (OTCPK:SHPMF), for $608 million (RMB 4.5 billion) in cash .
Hong Kong-based pharma said Chinese private
